Gamma interferon and 1,25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cell line. 1986

E D Ball, and A L Howell, and L Shen

The physiological agents gamma interferon and 1,25 dihydroxyvitamin D3 (calcitriol) are both potent inducers of monocytoid differentiation in the HL-60 promyelocytic leukemia cell line. However, the populations resulting from treatment with either inducer have differing properties, suggesting that these agents do not have identical modes of action. In this study we have compared the effects of gamma interferon (IFN gamma) and calcitriol and examined the effect of exposing HL-60 cells to both compounds simultaneously. In addition, we have examined the effects of inhibitors of protein and RNA synthesis on induction of cell surface antigens in order to gain insight into the mechanisms of action of these compounds. We found that combining IFN gamma and calcitriol resulted in greater monocytic differentiation of HL-60 cells than did either compound alone. In addition, a monocyte-associated cell surface antigen, My23, and class-I HLA antigen were induced by both agents in at least an additive manner. In contrast, combined treatment with both compounds did not augment antibody-dependent cellular cytotoxicity (ADCC) any better than did IFN gamma alone, but it did cause a decrease in the density of receptors for the Fc portion of immunoglobulin. In studies examining the effects of IFN gamma and calcitriol on the cloning potential of HL-60 cells, we found that incubation of cells with either compound alone significantly reduced the number of HL-60 colonies, and both compounds added together caused an almost total elimination of colony-forming cells. Inhibition of RNA synthesis with alpha amanitin had no effect on the action of IFN gamma on cell surface HLA, but did block the induction of My23 antigen, suggesting that the mechanism of HLA induction may involve posttranscriptional phenomena. RNA-synthesis blockade inhibited the ability of calcitriol to induce My23. These studies demonstrate that multiple and separable events accompany the monocytoid differentiation of HL-60 cells induced by different chemical mediators and that different intracellular pathways may be involved.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E D Ball, and A L Howell, and L Shen
April 1984, The Journal of clinical investigation,
E D Ball, and A L Howell, and L Shen
December 1991, Journal of nutritional science and vitaminology,
E D Ball, and A L Howell, and L Shen
April 2006, Biomedical research (Tokyo, Japan),
E D Ball, and A L Howell, and L Shen
January 1995, Blood cells, molecules & diseases,
Copied contents to your clipboard!